Companies

Stryker Corporation has reported its operating results for the second quarter of 2012 with net sales of $2.1 billion, up 2.9%. Neurotechnology and Spine divisional sales showed greatest percentage growth, although all divisions were up over the equivalent quarter a year ago.

Abbott has announced its financial results for the second quarter ended June 30, 2012. Reported sales increased 2.0 percent, including an unfavourable 4.7 percent effect of foreign exchange. Stent sales suffered due to the wind-down of the supply arrangement with Boston Scientific, but recent Xience news gives reason for optimism.

St. Jude Medical, Inc. has reported sales and net earnings for the second quarter ended June 30, 2012. Compared with the equivalent period a year ago net sales of $1.410 billion represented a decrease of 2 percent, declines in Cardiac Rhythm Management sales being somewhat offset by increases in Atrial Fibrillation and Neuromodulation revenues.

UK device company Surgical Innovations welcomed some of the best minds in UK surgery to its annual event last week in what forms a key part of the company’s surgeon-led product and idea-development philosophy.

Steris Corporation is to acquire United States Endoscopy Group, Inc. and in so doing significantly expand its presence in the gastrointestinal(GI) procedural market with a franchise of proprietary, single-use consumable medical devices.

In a press release issued today via Globe Newswire, Mako Surgical Corp. has announced that Steven J. Nunes has tendered his resignation as MAKO’s Senior Vice President of Sales & Marketing effective July 17, 2012.

Johnson & Johnson has just announced sales of $16.5 billion for the second quarter of 2012, a decrease of 0.7% as compared to the second quarter of 2011, albeit with a significant currency loss painting a gloomier picture than the top line figures suggest.

St. Jude Medical, Inc., has gone public with initial findings from its Riata Lead Evaluation Study. The study’s phase-one results found that externalised conductors occurred in 9.3 percent of the smaller-diameter Riata ST 7F leads in the study, and in 24 percent of the larger-diameter Riata 8F leads.

NeuroLogica has announced the integration of NeuroLogica’s portable BodyTom™ 32-slice CT scanner with Medtronic’s StealthStation® S7® surgical navigation system.

Critical care monitoring expert Sphere Medical Holding plc, and cardiovascular devices company Sorin Group, have jointly announced today that Sorin Group has placed an order with Sphere Medical for cardiopulmonary bypass monitors and microanalyser consumables (CPB) for delivery in Q4 2012.

9 patient deaths are reportedly linked with catheter entrapment when delivering Covidien subsidiary ev3’sOnyx injectable embolic material into the brain. FDA has seen fit to warn users of the potential for this to occur.

Vascular disease specialist Veryan has announced the appointments of Todd M. Pope and Jeffrey B. Jump as Non-Executive Directors. Both have many years’ experience of the medical device industry.

In this guest editorial, submitted by John Martin of legal marketing specialist firm eJustice, he reports on FDA’s most recent review of the ongoing all-metal hip debacle.

Cook Medical has gained 510(k) clearance for its Evolution® Colonic Controlled-Release Stent. The new stent is used to palliate uncomfortable symptoms associated with colonic obstructions caused by malignant neoplasms and relieve large-bowel obstructions prior to colectomy procedures.

Eucomed, the European Medical Technology Industry Association, and EDMA, the European Diagnostic Manufacturers Association, have announced the appointment of Serge Bernasconi as Chief Executive of both associations.

Cartiheal, a privately held device company developing an innovative cell-free technology for regenerating hyaline cartilage, has raised up to $10 million which it will use to accelerate the development of Agili-CTM, as well as support ongoing clinical studies.